岩藻糖基化与肿瘤多药耐药
作者:
作者单位:

1.齐齐哈尔医学院药学院,黑龙江 齐齐哈尔 161006;2.齐齐哈尔医学院医药科学研究院,黑龙江 齐齐哈尔 161006

作者简介:

通讯作者:

中图分类号:

R-33

基金项目:


Fucosylation and multidrug resistance of tumors
Author:
Affiliation:

1. College of Pharmacy, Qiqihar Medical University, Qiqihar 161006, China. 2. Research Institute of Medical Sciences and Pharmacy, Qiqihar Medical University, Qiqihar 161006

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    岩藻糖基化是最常见的糖基化修饰之一,与癌症的发生发展及预后密切相关。有研究报道,岩藻糖基转移酶的变化与肿瘤多药耐药具有一定的相关性,肿瘤细胞多药耐药是影响临床化疗效果的最重要因素之一,常常导致治疗效果不佳、患者预后不良等。本文重点介绍了岩藻糖基转移酶家族成员及其催化的岩藻糖基化修饰与肿瘤多药耐药的相关性,简述了岩藻糖基化抑制剂对肿瘤的治疗作用,提出岩藻糖类似物作为岩藻糖基化抑制剂有可能成为逆转肿瘤多药耐药的潜在药物,为将岩藻糖基化修饰作为临床肿瘤耐药逆转和增敏的药物靶点提供依据。

    Abstract:

    Fucosylation is one of the most common glycosylation modifications that is closely related to the occurrence, development, and prognosis of cancer. A change in fucosyltransferase correlations with tumor multidrug resistance has been reported. Multidrug resistance of tumor cells is a major factor affecting chemotherapy efficacy, which often leads to a poor therapeutic effect and prognosis. This review focuses on the relationship between fucosyltransferase family members and their catalytic fucosylation modification and tumor multidrug resistance, briefly summarizes the therapeutic effect of fucosylation inhibitors on tumors, and describes fucosylation analogues as fucosylation inhibitors that may be potential drugs to reverse tumor multidrug resistance. This article provides a basis for fucosylation modification as a drug target to reverse and sensitize tumor drug resistance.

    参考文献
    相似文献
    引证文献
引用本文

冯 博,刘姿宇,李 月,刘立琨,岳丽玲.岩藻糖基化与肿瘤多药耐药[J].中国比较医学杂志,2023,33(1):113~118.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-04-21
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-03-16
  • 出版日期:
自2024年1期开始,杂志参考文献改为中英文对照,具体格式要求可置下载中心查看!
关闭